Bacterial 30S ribosomal subunit aminoacyl-tRNA site (30S A-site)

The bacterial 30S ribosomal subunit aminoacyl-tRNA site (A-site) is a fundamental component of the bacterial translation apparatus, located within the decoding center of the 16S ribosomal RNA (Nature Reviews Microbiology, 2016). Its primary biological role is to facilitate the accurate selection of aminoacyl-tRNA molecules based on the messenger RNA (mRNA) codon sequence, ensuring high-fidelity protein synthesis (PubMed, 11158313). This site is a major therapeutic target for several classes of broad-spectrum antibiotics, including aminoglycosides and tetracyclines. Aminoglycosides bind to the A-site and induce a 'flipped-out' conformation of specific adenine residues, which stabilizes near-cognate tRNA binding and results in lethal mistranslation (StatPearls, NBK541030). Tetracyclines act by physically blocking the A-site, preventing the entry of aminoacyl-tRNA and thus halting protein elongation (StatPearls, NBK549905). The structural differences between the bacterial 30S A-site and the eukaryotic 40S A-site provide the basis for selective toxicity, although high doses can sometimes affect mitochondrial ribosomes, leading to adverse effects such as ototoxicity and nephrotoxicity.

Other names

16S rRNA A-siteDecoding centerAminoacyl-tRNA binding site30S ribosomal A-siteRibosomal decoding site

Antibiotics targeting the 30S A-site primarily inhibit bacterial protein synthesis through two distinct mechanisms. Aminoglycosides bind to the 16S rRNA within the A-site, inducing a conformational change (specifically the flipping out of residues A1492 and A1493) that stabilizes the binding of near-cognate tRNAs, leading to mRNA misreading and the production of aberrant, toxic proteins (StatPearls, NBK541030). Tetracyclines bind to the 30S subunit and physically block the A-site, preventing the entry and binding of aminoacyl-tRNA, which halts the addition of new amino acids to the growing peptide chain (StatPearls, NBK549905).